Literature DB >> 2904369

Unencapsulated Haemophilus influenzae--what kind of pathogen?

P H Mäkelä1.   

Abstract

Haemophilus influenzae are small, gram-negative, rod-shaped bacteria. Because of their special growth requirements, they do not grow on usual blood agar media, but flourish on the mucosal membranes of the human respiratory tract where they adhere to the epithelial cells by fimbriae (a potential vaccine component). Nasopharyngeal carriage of Haemophilus influenzae is very common, and in healthy carriers the bacteria are usually unencapsulated. The outer membrane of Haemophilus influenzae contains lipopolysaccharide (of so called R form, without O antigen) and major outer membrane proteins. The lipopolysaccharide is a virulence determinant. An extracellular enzyme, IgA protease, is another potential virulence determinant. The outer membrane of Haemophilus influenzae is a rather ineffective barrier towards antibiotics, and thus the major determinants of antibacterial resistance in Haemophilus influenzae are plasmid-coded enzymes that inactivate the antibiotic, and changes in the target molecules.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2904369     DOI: 10.1007/BF01964236

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  28 in total

Review 1.  Molecular basis of bacterial outer membrane permeability.

Authors:  H Nikaido; M Vaara
Journal:  Microbiol Rev       Date:  1985-03

2.  Effect of a toxin produced by Haemophilus influenzae on ciliated respiratory epithelium.

Authors:  F W Denny
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

Review 3.  Lipopolysaccharide nomenclature--past, present, and future.

Authors:  P J Hitchcock; L Leive; P H Mäkelä; E T Rietschel; W Strittmatter; D C Morrison
Journal:  J Bacteriol       Date:  1986-06       Impact factor: 3.490

4.  Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine.

Authors:  H Peltola; H Käyhty; M Virtanen; P H Mäkelä
Journal:  N Engl J Med       Date:  1984-06-14       Impact factor: 91.245

5.  Adherence of Haemophilus influenzae to buccal epithelial cells.

Authors:  R M Lampe; E O Mason; S L Kaplan; C L Umstead; M D Yow; R D Feigin
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

6.  Penicillin-binding proteins in Haemophilus influenzae.

Authors:  S D Makover; R Wright; E Telep
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

7.  Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.

Authors:  J Eskola; H Peltola; A K Takala; H Käyhty; M Hakulinen; V Karanko; E Kela; P Rekola; P R Rönnberg; J S Samuelson
Journal:  N Engl J Med       Date:  1987-09-17       Impact factor: 91.245

8.  Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates.

Authors:  R Schneerson; J B Robbins; J C Parke; C Bell; J J Schlesselman; A Sutton; Z Wang; G Schiffman; A Karpas; J Shiloach
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

9.  Haemophilus influenzae type b lipooligosaccharide: stability of expression and association with virulence.

Authors:  A Kimura; C C Patrick; E E Miller; L D Cope; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

10.  Purification and characterization of Haemophilus influenzae pili, and their structural and serological relatedness to Escherichia coli P and mannose-sensitive pili.

Authors:  N G Guerina; S Langermann; G K Schoolnik; T W Kessler; D A Goldmann
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

View more
  3 in total

1.  Evaluation of the virulence of nontypeable Haemophilus influenzae lipooligosaccharide htrB and rfaD mutants in the chinchilla model of otitis media.

Authors:  T F DeMaria; M A Apicella; W A Nichols; E R Leake
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

2.  Broth microdilution testing of Haemophilus influenzae with haemophilus test medium versus lysed horse blood broth. Canadian Haemophilus Study Group.

Authors:  S R Scriver; D E Low; A E Simor; B Toye; A McGeer; R Jaeger
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

3.  Nontypeable Haemophilus influenzae: pathogenesis and prevention.

Authors:  A R Foxwell; J M Kyd; A W Cripps
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.